Bank of New York Mellon
AEMD icon

Bank of New York Mellon’s Aethlon Medical AEMD Stock Holding History

Bank of New York Mellon’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7
Closed -$10.7K – 4382
2023
Q1 		$10.7K Hold
7
– – ﹤0.01% 4352
2022
Q4 		$7.68K Hold
7
– – ﹤0.01% 4434
2022
Q3 		$16K Hold
7
– – ﹤0.01% 4472
2022
Q2 		$31K Hold
7
– – ﹤0.01% 4442
2022
Q1 		$42K Hold
7
– – ﹤0.01% 4546
2021
Q4 		$53K Hold
7
– – ﹤0.01% 4491
2021
Q3 		$111K Buy
+7
New +$118K ﹤0.01% 4314
2019
Q1 		– Sell
-1
Closed -$50K – 4208
2018
Q4 		$50K Buy
+1
New +$72.4K ﹤0.01% 4060
2018
Q2 		– Hold
0
– -$20K – 4205
2018
Q1 		– Hold
0
– – – 4268
2017
Q2 		– Hold
0
– -$56K – 4291
2017
Q1 		– Hold
0
– – – 4124
2016
Q1 		– Hold
0
– -$111K – 4213
2015
Q4 		– Hold
0
– – – 4034

Other funds holding AEMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
AFGAS
Allegiance Financial Group Advisory Services Vienna, Virginia $578M AUM 24.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Bank of New York Mellon's AEMD Position: Q2 2023 in Review

Bank of New York Mellon sold out of Aethlon Medical (AEMD) in Q2 2023, closing a stake of 7 shares — an estimated $10.7K sold.

Bank of New York Mellon first reported a position in AEMD in Q4 2018 and held it in 8 quarters. The position peaked at $111K in Q3 2021. 18 funds tracked by Wall St. Rank hold AEMD as of Q2 2023.

  • Bank of New York Mellon reported no remaining Aethlon Medical position as of Q2 2023 after selling out during the quarter.
  • Bank of New York Mellon sold 7 Aethlon Medical shares in Q2 2023, an estimated $10.7K.
  • Bank of New York Mellon first reported a position in Aethlon Medical in Q4 2018 and held it in 8 quarters.
  • Bank of New York Mellon's Aethlon Medical position peaked at $111K in Q3 2021.
  • 18 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2023.

Based on Bank of New York Mellon's 13F filing for Q2 2023, filed 3 Aug 2023.